The North American market size for radiation dose management is estimated to grow at a CAGR of 13.52% from 2022 to 2027 and be worth USD 156.12 million by 2027 from USD 82.81 million in 2022.
Radiation exposure in patients undergoing computed tomography (CT) has increased, resulting in burns and radiation poisoning. Manufacturers include technology for precise dose prediction for a CT process due to high dosage exposures while conducting CT scans. The risk of radiation exposure to patients is reduced with new CT equipment that includes dose reduction hardware and software. For example, Bayer's Radimetric Enterprise Platform automates dose documentation with Certegra and the Medrad Stellant CT injectable device. Because it captures the image of the entire brain with a single 640-slice rotation, the Canon Medical Systems Aquilion One/Genesis Edition CT can eliminate the necessity for multimodality studies. It also reduces the amount of radiation dosage by up to 82.4 percent while reducing the amount of noise produced during treatment. The Aquilion Precision System, the first ultra-high-resolution computed tomography system, was approved by the Food and Drug Administration (FDA).
Due to having high-end CT equipment, most hospitals and imaging centers are swiftly adopting cutting-edge dose reduction technology solutions. The dose monitoring program saves time and effort at CT centers by automating the collection of doses. This is also useful for detecting incorrect dose choices early on. As a result, the radiation dose management market in North America is likely to grow at a healthy rate during the forecast period.
On the other hand, government-defined guidelines for radiation dose benchmarking across all radiology procedures do not exist. Therefore, dose management software cannot be leveraged entirely to reduce dose due to the lack of established practices. The American College of Radiology has been attempting to develop national guidelines for CT treatments through DIR since 2011, however, benchmarking for all imaging modalities must be done globally.
On a global scale, consistent protocols are required for examinations, imaging modalities, and patients of all sizes and ages. An individual would be able to monitor dose indices and compare standard dose reduction measures followed by similar healthcare provider facilities at the regional, state, and national levels if thorough benchmarking criteria and established procedures were available.
This report on the North American radiation dose management market has been segmented and sub-segmented into the following categories.
By Product and Services:
By Technology:
By Application:
By End-User:
By Country:
Over the forecast period, the North American region is expected to account for around 37% of the share in the global market and benefit from the region's sophisticated healthcare infrastructure, established vendors, and rising acceptance of technologically advanced radiation dose management products. Furthermore, due to the growth in the frequency of chronic diseases such as cancer, the availability of sophisticated technologies, and improved awareness of radiation dose management, the market in North America is expected to develop throughout the forecast period. According to a Harvard Medical School study, roughly 80 million CT scans are performed in the United States each year. CT angiography, colonography, and dual-energy and perfusion CT are just a few of the scanning technologies that have revolutionized how physicians diagnose and treat patients.
On the other hand, excessive ionizing radiation exposure is becoming a significant concern due to the dangers it poses. As a result, radiology departments are performing CT scans with minimal doses. For precise assessment of radiation doses that can be compared with reference standards, many research centers and hospitals are adopting powerful state-of-the-art CT equipment coupled with software and ERPs. The average dosage is calculated using the past CT examination doses by the dose tracking software. Due to the aforementioned factors, the U.S. radiation dose management market is likely to grow at a healthy rate throughout the forecast period.
KEY MARKET PLAYERS:
Bayer AG, Mckesson Corporation, AGFA Healthcare, GE Healthcare Ltd., Sectra Medical Systems GmbH, Fujifilm Holdings Corporation, PACS Health LLC, Koninklijke Philips N.V., Siemens Healthcare Diagnostics Inc., Novarad Corporation, and Toshiba Medical Systems Corporation are some of the major players in the North America radiation dose management market profiled in this report.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region